The next focusIR Investor Webinar takes place tomorrow with guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksReneuron Regulatory News (RENE)

  • This share is currently suspended. It was suspended at a price of 3.275

Share Price Information for Reneuron (RENE)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 3.275
Bid: 0.00
Ask: 0.00
Change: 0.00 (0.00%)
Spread: 0.00 (0.00%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 3.275
RENE Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Notification of Major Holdings

5 Mar 2019 07:00

RNS Number : 8084R
ReNeuron Group plc
05 March 2019
 

TR-1: Standard form for notification of major holdings

 

 

1a. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached:

ReNeuron Group PLC

LEI: 2138003TU12CQ5TZO137

1b. Please indicate if the issuer is a non-UK issuer (please mark with an "X" if appropriate)

Non-UK issuer

 

2. Reason for the notification (please mark the appropriate box or boxes with an "X")

An acquisition or disposal of voting rights

X

An acquisition or disposal of financial instruments

 

An event changing the breakdown of voting rights

 

Other (please specify):

 

3. Details of person subject to the notification obligation

Name

Invesco Ltd.

City and country of registered office (if applicable)

1555 Peachtree Street NE, Suite 1800,

Atlanta, GA 30309 United States

4. Full name of shareholder(s) (if different from 3.)

Name

 

City and country of registered office (if applicable)

 

5. Date on which the threshold was crossed or reached:

01-03-2019

6. Date on which issuer notified (DD/MM/YYYY):

04-03-2019

7. Total positions of person(s) subject to the notification obligation

 

% of voting rights attached to shares (total of 8. A)

% of voting rights through financial instruments(total of 8.B 1 + 8.B 2)

Total of both in % (8.A + 8.B)

Total number of voting rights of issuer

Resulting situation on the date on which threshold was crossed or reached

9.89%

0

9.89%

31,646,186

Position of previous notification (if

applicable)

11.91%

0

11.91%

 

       

 

8. Notified details of the resulting situation on the date on which the threshold was crossed or reached

A: Voting rights attached to shares

Class/type ofshares

ISIN code (if possible)

 

GB00BF5G6K95

Number of voting rights

% of voting rights

Direct

(Art 9 of Directive 2004/109/EC) (DTR5.1)

Indirect

(Art 10 of Directive 2004/109/EC) (DTR5.2.1)

Direct

(Art 9 of Directive 2004/109/EC) (DTR5.1)

Indirect

(Art 10 of Directive 2004/109/EC) (DTR5.2.1)

 

 

3,132,955

 

9.89%

 

 

 

 

 

 

 

 

 

 

SUBTOTAL 8. A

3,132,955

9.89%

 

 

B 1: Financial Instruments according to Art. 13(1)(a) of Directive 2004/109/EC (DTR5.3.1.1 (a))

Type of financial instrument

Expirationdate

Exercise/Conversion Period

Number of voting rights that may be acquired if the instrument is

exercised/converted.

% of voting rights

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

SUBTOTAL 8. B 1

 

 

 

 

B 2: Financial Instruments with similar economic effect according to Art. 13(1)(b) of Directive 2004/109/EC (DTR5.3.1.1 (b))

Type of financial instrument

Expirationdat

Exercise/Conversion Period 

Physical or cash

settlement

Number of voting rights

% of voting rights

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

SUBTOTAL 8.B.2

 

 

 

 

 

          

 

9. Information in relation to the person subject to the notification obligation (please mark the

applicable box with an "X")

Person subject to the notification obligation is not controlled by any natural person or legal entity and does not control any other undertaking(s) holding directly or indirectly an interest in the (underlying) issuer

 

Full chain of controlled undertakings through which the voting rights and/or thefinancial instruments are effectively held starting with the ultimate controlling natural person or legal entity (please add additional rows as necessary)

X

Name

% of voting rights if it equals or is higher than the notifiable threshold

% of voting rights through financial instruments if it equals or is higher than the notifiable threshold

Total of both if it equals or is higher than the notifiable threshold

Invesco Asset

Management Ltd.

9.89%

0

9.89%

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

10. In case of proxy voting, please identify:

Name of the proxy holder

Invesco (UK) Ltd.

The number and % of voting rights held

N/A

The date until which the voting rights will be held

N/A

 

11. Additional information

 

     

 

Place of completion

Henley-on-Thames

Date of completion

04-03-2019

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
HOLUGUUCWUPBGBC
Date   Source Headline
19th Dec 20114:41 pmRNSSecond Price Monitoring Extn
19th Dec 20114:35 pmRNSPrice Monitoring Extension
6th Dec 201110:00 amRNSWelcomes UK Government Life Sciences Strategy
30th Nov 20114:35 pmRNSPrice Monitoring Extension
28th Nov 20117:00 amRNSStroke Update
28th Nov 20117:00 amRNSInterim Results
9th Nov 20117:00 amRNSStroke clinical trial update & notice of results
3rd Nov 20112:54 pmRNSNotification of Major Interest in Shares
1st Nov 20112:13 pmRNSNotification of Interest in Shares
31st Oct 201110:42 amRNSNotification of Major Interest in Shares
22nd Sep 201112:53 pmRNSDirectors' Interest in Shares and Share Options
22nd Sep 201112:48 pmRNSDirectors' Interest in Shares
15th Sep 201110:45 amRNSResults of 2011 Annual General Meeting
15th Sep 20117:00 amRNSAGM Trading Update
1st Sep 20114:35 pmRNSPrice Monitoring Extension
1st Sep 20117:00 amRNSReNeuron receives DSMB clearance
29th Jul 20113:24 pmRNSAnnual Report and Accounts and Notice of AGM
20th Jul 20117:00 amRNSBoard Appointments
5th Jul 20117:00 amRNSContract with Angel Biotechnology Holdings plc
5th Jul 20117:00 amRNSAngel signs new contract with ReNeuron
30th Jun 20117:00 amRNSPreliminary Results
24th Jun 20112:56 pmRNSReNeuron launches new website
16th Jun 20117:00 amRNSLicense agreement with US eye research institute
1st Jun 20119:43 amRNSBlock Listing Six Monthly Review
27th May 20117:00 amRNSNotice of Results and Stroke Clinical Trial Update
28th Apr 201112:22 pmRNSEU legal opinion
8th Apr 20117:00 amRNSManufacturing Agreement
28th Jan 20117:00 amRNSSettlement with Neuralstem, Inc
10th Jan 20112:18 pmRNSTR-1 Notification of major interest in shares
10th Jan 20117:00 amRNSTR-1 Notification of major interest in shares
7th Jan 20117:00 amRNSTR-1: Notification of major interest in shares
4th Jan 20117:00 amRNSMajor Interest in Shares
29th Dec 201011:34 amRNSRESULT OF GENERAL MEETING & THIRD ADMISSION
21st Dec 20107:00 amRNSUpdate on clinical trial
20th Dec 20108:01 amRNSSECOND ADMISSION
17th Dec 20108:01 amRNSFIRST ADMISSION
13th Dec 20107:01 amRNSInterim Results
13th Dec 20107:00 amRNS£10 million Fundraising
1st Dec 20107:00 amRNSBlock Listing Six Monthly Review
17th Nov 20104:41 pmRNSSecond Price Monitoring Extn
17th Nov 20104:35 pmRNSPrice Monitoring Extension
17th Nov 20107:00 amRNSProgress update on ReN009
16th Nov 20107:00 amRNSFirst Patient Treated with ReN001
27th Oct 20107:00 amRNSReNeuron at stem cell and neuroscience conferences
8th Oct 201010:26 amRNS18th Annual BioPartnering Europe conference
8th Sep 201011:07 amRNSResults of 2010 Annual General Meeting
8th Sep 20107:00 amRNS2010 AGM Trading Update
9th Aug 20107:00 amRNSPosting of Report and Accounts and AGM date
3rd Aug 20107:00 amRNSDirector/PDMR Shareholding
15th Jul 20107:00 amRNSNotification of Investor Evening

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.